Our approach

Led by purpose

We believe novel technologies like machine learning, molecular biology, and whole genome sequencing will trigger a step-change in healthcare. Sepsis and AMR are universal threats which require a universal solution.

Partnering for greater impact

GenomeKey believes nobody should die of a treatable infection, and we mean nobody globally. To achieve this we need global partners. We are the only company in the world with a viable, low-cost and accessible solution which can be used worldwide to tackle the number one cause of death.

Become a GenomeKey partner today


Register your interest as an investor and we will contact you when we are next raising funding.

R&D Partners

Work with us to deliver a more robust, reliable and comprehensive diagnostic device to tackle the leading cause of death.

Clinical Partners

We always welcome clinical partnerships to support our journey and test our technology. We would love to hear from you.

Want to find out more?

Help us transform the diagnostic process for bacteria. Contact us now to get involved or learn more about our technology.


Thank you, we'll be in touch soon.